IgA as a Blocking Factor in Human Malignant Melanoma
- 1 January 1974
- journal article
- research article
- Published by Taylor & Francis in Immunological Communications
- Vol. 3 (5) , 427-438
- https://doi.org/10.3109/08820137409061123
Abstract
Immunoglobulin A (IgA), isolated from the serum of patients with malignant melanoma, was found capable of abrogating the cytotoxic effect of sensitized lymphocytes on human melanoma target cells in vitro. IgG and IgM from melanoma serum, as well as IgA, IgG, and IgM from normal serum, did not have this ability. Blocking activity could be removed from melanoma serum or IgA fractions by absorption with melanoma tumor cells or antihuman IgA antiserum.Keywords
This publication has 20 references indexed in Scilit:
- Cell-mediated and humoral immune reactions to human tumoursInternational Journal of Cancer, 1973
- Sequential studies on cell‐mediated tumor immunity and blocking serum activity in ten patients with malignant melanomaInternational Journal of Cancer, 1973
- Cytotoxic lymphocytes in melanoma patientsInternational Journal of Cancer, 1972
- Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytesInternational Journal of Cancer, 1972
- Cellular and humoral immunity against human malignant melanomaInternational Journal of Cancer, 1971
- Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody ComplexesProceedings of the National Academy of Sciences, 1971
- Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasmsInternational Journal of Cancer, 1971
- Demonstration of cell‐mediated immunity to human neoplasms of various histological typesInternational Journal of Cancer, 1971
- SERUM-MEDIATED PROTECTION OF NEOPLASTIC CELLS FROM INHIBITION BY LYMPHOCYTES IMMUNE TO THEIR TUMOR-SPECIFIC ANTIGENSProceedings of the National Academy of Sciences, 1969
- Transplantation Immunity : Localization in Mouse Serum of Antibodies Responsible for Haemagglutination, Cytotoxicity and EnhancementNature, 1966